COMBACTE

COMBACTE

Tackling Antimicrobial Resistance in Europe

According to the World Health Organization ‘Antibiotic resistance is becoming a public health emergency of yet unknown proportions’. In the European Union, antimicrobial resistance, or AMR is responsible for some 25.000 deaths every year. Meanwhile, new forms of resistance continue to arise and spread, leaving clinicians with few weapons to bring infections under control. Yet despite the recognised need for new antibiotics, the reality is that only two new classes of antibiotics have been brought to the market in the last three decades.

COMBACTE is one of the projects of the IMI’s New Drugs 4 Bad Bugs (ND4BB) programme which tackles the scientific, regulatory, and economic challenges of developing new antibiotics to combat antibiotic resistance in Europe.

Also watch the long version of this video. 

imi.europa.eu